Comparative, Clinico-Epidemiologic Study of Schistosoma mansoni Infections in Travellers and Immigrants in Spain

[1]  L. Chitsulo,et al.  The global status of schistosomiasis and its control. , 2000, Acta tropica.

[2]  M. Tanner,et al.  Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial , 2000, The Lancet.

[3]  B. Tarp,et al.  The immunofluorescence antibody test (IFAT) for the diagnosis of schistosomiasis used in a non‐endemic area , 2000, Tropical medicine & international health : TM & IH.

[4]  M. Doenhoff,et al.  Short communication: Detection of praziquantel resistance in schistosomes , 2000, Tropical medicine & international health : TM & IH.

[5]  D. Bundy,et al.  Anthelmintics. A comparative review of their clinical pharmacology. , 1997, Drugs.

[6]  A. Moody,et al.  Lesson of the Week: Katayama fever: an acute manifestation of schistosomiasis , 1996, BMJ.

[7]  D. Bundy,et al.  Anthelmintic chemotherapy: the individual and the community , 1995 .

[8]  S. Watts,et al.  The public health implications of the increasing predominance of Schistosoma mansoni in Egypt: a pilot study in the Nile delta. , 1995, The Journal of tropical medicine and hygiene.

[9]  P. Winch,et al.  Prevalence and epidemiology of Schistosoma mansoni and S. haematobium infection in two areas of Egypt recently reclaimed from the desert. , 1995, The American journal of tropical medicine and hygiene.

[10]  R. Davidson,et al.  Acute schistosomiasis (Katayama fever) among British air crew. , 1988, BMJ.

[11]  R. Russell,et al.  A review of schistosomiasis in immigrants in Western Australia, demonstrating the unusual longevity of Schistosoma mansoni. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  A. Davis,et al.  The schistosomiasis problem in the world: results of a WHO questionnaire survey. , 1981, Bulletin of the World Health Organization.